Showing posts with label health news. Show all posts
Showing posts with label health news. Show all posts

Saturday, July 4, 2020

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death
The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.

The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The United States accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.

“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” the WHO said in a statement, referring to large multicountry trials that the agency is leading.

The U.N. agency said the decision, taken on the recommendation of the trial’s international steering committee, does not affect other studies where those drugs are used for non-hospitalised patients or as a prophylaxis.

Another branch of the WHO-led trial is looking at the potential effect of Gilead’s antiviral drug remdesivir on COVID-19. The European Commission on Friday gave remdesivir conditional approval for use after being shown to shorten hospital recovery times.

The solidarity trial started out with five branches looking at possible treatment approaches to COVID-19: standard care; remdesivir; hydroxychloroquine; lopinavir/ritonavir; and lopanivir/ritonavir combined with interferon.

WHO director-general Tedros Adhanom Ghebreyesus told reporters on Friday that nearly 5,500 patients in 39 countries had been recruited so far into its clinical trials and that interim results were expected within two weeks.

Some 18 experimental COVID-19 vaccines are being tested on humans among nearly 150 treatments under development.

Mike Ryan, WHO’s top emergencies expert, said on Friday that it would be unwise to predict when a vaccine could be ready. While a vaccine candidate might show its effectiveness by year’s end, the question was how soon it could then be mass-produced, he said.



from Health - SUCH TV https://ift.tt/2Z2kyxL

Wednesday, May 29, 2019

France to ban widely used crop fungicide over health concerns

France to ban widely used crop fungicide over health concerns

France to ban widely used crop fungicide over health concerns
France’s health and safety regulator has decided to ban a widely used crop fungicide after classifying it as a so-called endocrine disruptor posing risks for humans and the environment.

The ANSES agency said on Tuesday it was withdrawing the marketing license for 76 products containing epoxiconazole, which is commonly applied to protect cereal and sugar beet fields in France, the European Union’s biggest crop producer.

“The agency’s conclusion is that epoxiconazole is an endocrine disruptor for humans and non-target organisms, and represents a preoccupying level of danger for humans and the environment,” it said in a statement.

ANSES decided to review the chemical following new EU regulations concerning endocrine disruptors, which are suspected of affecting humans’ hormone systems and causing diseases including cancer, it said.

A spokeswoman for the regulator said that around half of French cereals and 70% of sugar beet crops were treated with epoxiconazole-based products.

There would be a transition period of around one year to allow stocks of the fungicide to be used up, after which farmers could use alternative products that exist on the market, she said.

ANSES did not detail the products to be withdrawn from the market.



from Health - SUCH TV http://bit.ly/2Xejkw2

Tuesday, May 21, 2019

Dr Zafar Mirza in Geneva to attend World Health Assembly

Dr Zafar Mirza in Geneva to attend World Health Assembly

Minister of State for National Health Services, Regulations and Coordination Dr Zafar Mirza
Minister of State for National Health Services, Regulations and Coordination Dr Zafar Mirza Monday reached Geneva as head of Pakistani delegation to attend 194 nations World Health Assembly.

On his arrival, he said today’s world health is a shared responsibility, involving equitable access to essential care and collective defense against transnational threats, a statement received here said.

He said the World Health Assembly is the supreme decision-making forum where nations of the world converge to deliberate and devise strategies for promoting health and reducing disease burden.

He said delegations led by health minister from all over the world are in Geneva to attend the World Health Assembly.

“I will present the major reform agenda of our government under the leadership for Prime Minister Imran Khan,” the minister said.

He said there will be an opportunity to showcase progress made in different areas alongside our challenges and approaches adopted to overcome them, he added.

“Universal Health Coverage which is also the theme of this year’s World Health Assembly will be our area of focus besides efforts to align our health reforms with WHO General Program of Work 2030.”

He said, “I look forward to holding important meetings with health ministers of different countries to discuss mutual cooperation in the field of health.”

He said, “I will also be meeting WHO director general and regional director alongside meeting heads and senior leaderships of leading donor organizations including Bill and Melinda Gates Foundation, Global Fund for AIDS, Tuberculosis and Malaria, Global Alliance for vaccines and immunization amongst others to discuss ongoing collaborative programs aimed at improving the health and well being of the people of Pakistan.”



from Health - SUCH TV http://bit.ly/2HqH9ek

Monday, May 20, 2019

Smokers have higher risk for multiple strokes

Smokers have higher risk for multiple strokes

Smokers have higher risk for multiple strokes
Smokers who have a stroke are much more likely to have another one if they don’t quit or at least cut back, a Chinese study suggests.

Smoking has long been linked to an increased risk of cardiovascular disease and serious cardiac events like heart attacks and strokes. But the new study sheds light on how smoking influences the risk of a second stroke in patients who already had one.

Among the 3,069 stroke survivors in the study, 1,475, or 48 percent, were current smokers and another nine percent were former smokers.

Among the current smokers, 908, or 62 percent, managed to quit within a few months after their stroke.

As expected, smokers had a higher risk of a second stroke than people who never smoked at all, even if they managed to quit after their first stroke. However, smokers who did quit after that first stroke were 29 percent less likely to have a second one than people who kept smoking.

“Smoking after a stroke has the same effects on the body as before the first stroke,” said Allan Hackshaw, a researcher at University College London in the U.K. who wasn’t involved in the study.

“It can lead to problems with blood flow in the brain, and contribute to clots being formed in the blood vessels - and either of these increase the chance of having a stroke,” Hackshaw said by email. “Cutting back would reduce the risk a bit, but the study shows that quitting completely has a large reduction in the risk of a second stroke.”

All of the patients in the study survived for at least three months after a stroke.

Smokers’ risk of a repeat stroke rose with the number of daily cigarettes they smoked.

Compared to nonsmokers, current smokers who had up 20 cigarettes a day were 68 percent more likely to have a repeat stroke, while the risk was almost triple for smokers who had more than 40 cigarettes a day.

Current smokers tended to be younger and less likely to have conditions like high blood pressure, heart rhythm disorders or coronary heart disease than nonsmokers. They were also more likely to be heavy drinkers than nonsmokers.

The study wasn’t a controlled experiment designed to prove whether or how smoking causes repeat strokes.

One limitation of the study is the potential for smokers to go through other lifestyle changes when they quit - like improving eating and exercise habits - that contributed to a reduced stroke risk, Dr. Gelin Xu of Nanjing Medical University in Jiangsu, China, and colleagues note in the Journal of the American Heart Association. Xu didn’t respond to requests for comment.

Even so, the results add to a large body of evidence linking smoking cessation to a reduced risk of stroke, and continued smoking to an elevated stroke risk, said Dr. Michael Hill of the Cumming School of Medicine at the University of Calgary in Canada.

“Smoking is just about the worst possible thing you can do for your health,” Hill, who wasn’t involved in the study, said by email. “Yes, quitting helps a lot, but it is hard because it is addictive.”

 



from Health - SUCH TV http://bit.ly/2HCNdzp

Sunday, May 19, 2019

Common Diet Supplement May Help with Heart Health

Common Diet Supplement May Help with Heart Health

Researchers think glucosamine may help lower inflammation and help reduce risk of heart disease.
Glucosamine may help lower risk of cardiovascular disease, according to a new study.

A popular and widely used dietary supplement for joint pain could also be beneficial for your heart.

According to new research Trusted Source published in The BMJ, habitual use of the supplement glucosamine was found to be associated with a significantly lower risk of cardiovascular disease (CVD) and its more severe consequences like stroke.

However, researchers point out that despite this association, their work doesn’t establish a causal link between glucosamine and better CVD outcomes.

“Our study suggests a potential new beneficial effect of glucosamine on cardiovascular health. The practical implication would be upon further evidence from future studies, such as clinical trials, that verify such effects as causal,” said Dr. Lu Qi, a professor in the department of epidemiology at Tulane University and one of the study’s authors.

Nonetheless, the data from the study is robust.



from Health - SUCH TV http://bit.ly/2QbjFMY